InvestorsObserver
×
News Home

Will Nabriva Therapeutics PLC - ADR (NBRV) Stay at the Top of the Healthcare Sector?

Monday, January 09, 2023 12:28 PM | InvestorsObserver Analysts

Mentioned in this article

Will Nabriva Therapeutics PLC - ADR (NBRV) Stay at the Top of the Healthcare Sector?

Nabriva Therapeutics PLC - ADR (NBRV) is near the middle in its sector according to InvestorsObserver. NBRV gets an overall rating of 4. That means it scores higher than 4% of stocks. Nabriva Therapeutics PLC - ADR gets a 59 rank in the Healthcare sector. Healthcare is number 4 out of 11 sectors.

Overall Score - 4
NBRV has an Overall Score of 4. Find out what this means to you and get the rest of the rankings on NBRV!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. *Investors Observer* makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. Not only are these scores easy to understand, but it is easy to compare stocks to each other. You can find the best stock in healthcare or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Nabriva Therapeutics PLC - ADR Stock Today?

Nabriva Therapeutics PLC - ADR (NBRV) stock is trading at $1.31 as of 12:07 PM on Monday, Jan 9, a rise of $0.01, or 0.49% from the previous closing price of $1.30. Volume today is less active than usual. So far 81,348 shares have traded compared to average volume of 149,333 shares. The stock has traded between $1.22 and $1.33 so far today. Click Here to get the full Stock Report for Nabriva Therapeutics PLC - ADR stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App